Eldon C. Mayer III, Director at Eiger BioPharmaceuticals, Inc. (EIGR), bought 4,000 shares at $10.21 ($41K) on 2018-11-29, disclosed to the SEC on 2018-11-30.
Open-market purchase of $41k EIGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| EIGR | SELL | 2022-01-11 | $8K | — | Filing → |
| EIGR | SELL | 2021-01-11 | $20K | — | Filing → |
| EIGR | BUY | 2020-01-30 | $68K | — | Filing → |